Reducing Fetal Exposure to Maternal Depression to Improve Infant Risk Mechanisms

February 10, 2021 updated by: University of Illinois at Urbana-Champaign
This study evaluates Interpersonal Therapy (IPT) in the treatment of depression among pregnant women with elevated depressive symptoms. Half of the women will be randomized to receive IPT, and the other half will get Treat As Usual, provided via behavioral health in the hospital.

Study Overview

Detailed Description

Exposure to maternal depressive symptoms is one of the most well established risk factors for the development of later child psychopathology. Accumulating evidence from naturalistic observational studies documents that fetal exposure to maternal depressive symptoms is associated with risk for later child mental health problems. Maternal depression is one of the most common prenatal complications with approximately 40% of women experiencing elevated levels of depressive symptoms. The majority of past research has been correlational, so potential causal conclusions have been limited. This project will break new ground by testing the hypothesis that manipulating maternal depressive symptoms will benefit infant outcomes. In this project, maternal depressive symptoms will be reduced using brief interpersonal therapy (IPT), a well-established and efficacious treatment, and testing whether this reduction leads to an improvement in the development of infant mechanisms associated with risk for later psychopathology. The investigators propose to assess 300 pregnant women who report elevated levels of depressive symptoms and their infants. Prior to the intervention, maternal measures of depressive symptoms will be collected. Then half of the women will be randomized to receive IPT and the other half will receive enhanced usual care (TAU). After completion of the intervention, maternal measures will be collected longitudinally through 14 months postpartum. Infants will be evaluated at birth and two other times. Infants will be assessed across four units of analysis (brain structure and function, physiology, behavior, and maternal-report).

Study Type

Interventional

Enrollment (Anticipated)

240

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Denver, Colorado, United States, 80208
        • Recruiting
        • University of Denver
        • Contact:
    • Illinois
      • Urbana, Illinois, United States, 61801
        • Enrolling by invitation
        • University of Illinois

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Adult women (over 18 years of age)
  • A singleton intrauterine pregnancy
  • English speaking
  • Elevated depressive symptoms based on screening with the Edinburgh Postnatal Depression Scale (EPDS) with score > 9

Exclusion Criteria:

  • Bipolar disorder and psychosis based on the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-NP)
  • Current psychotropic medication use or current CBT/IPT usage
  • An HPA axis or an endocrine disorder
  • Maternal substance use [assessed using maternal report and urine toxicology
  • Corticosteroid medication use during this pregnancy
  • Invitto fertilization
  • Presence of cervical or uterine abnormalities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Behavioral: Interpersonal Therapy
Individual psychotherapy that includes an initial engagement session and a total of 8 sessions. IPT focuses on psychoeducation and interpersonal skill building to decrease interpersonal conflict and increase interpersonal support and competence.
reducing conflict in relationships, increasing social support in relationships, improving communication, reducing depressive symptoms
Other Names:
  • IPT
Placebo Comparator: Enhanced Usual Care
Maternity support services (MSS) is the usual standard of care for pregnant women. A multi-disciplinary team of obstetric care providers routinely screen women for possible depression diagnosis. If a woman screens positive, she is seen by a behavioral health specialist (BHS) for further assessment and to initiate treatment, if necessary. The goals of MSS include offering services to promote healthy pregnancies and positive birth and parenting outcomes, including integrating mental health and prenatal care. Women with elevated depressive symptoms are seen by BHS throughout the pregnancy and postpartum period and then bridged to mental health treatment. BHS provides eclectic-based care but does not provide IPT.
Treatment as Usual, including eclectic and supportive therapy, as well as psychiatric medication
Other Names:
  • Maternity Support Services (MSS)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence of a Major Depressive Episode on SCID interview
Time Frame: 12 months post pregnancy
Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation
12 months post pregnancy
Symptom Checklist 20 (SCL20)
Time Frame: post intervention (approximately 2-3 months post baseline)
Self reported Depression Scores. higher scores=more depression
post intervention (approximately 2-3 months post baseline)
Symptom Checklist 20 (SCL20)
Time Frame: 6 months post intervention
Self reported Depression Scores. higher scores=more depression
6 months post intervention
Symptom Checklist 20 (SCL20)
Time Frame: 12 months post intervention
Self reported Depression Scores. higher scores=more depression
12 months post intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Edinburgh Postnatal Depression Scale (EPDS)
Time Frame: post intervention (approximately 2-3 months post baseline)
Self reported Depression Scores. higher scores=more depression
post intervention (approximately 2-3 months post baseline)
Edinburgh Postnatal Depression Scale (EPDS)
Time Frame: 6 months post intervention
Self reported Depression Scores. higher scores=more depression
6 months post intervention
Edinburgh Postnatal Depression Scale (EPDS)
Time Frame: 12 months post intervention
Self reported Depression Scores. higher scores=more depression
12 months post intervention
Work and Social Adjustment Scale (WSAS)
Time Frame: post intervention (approximately 2-3 months post baseline)
general maternal functioning
post intervention (approximately 2-3 months post baseline)
Work and Social Adjustment Scale (WSAS)
Time Frame: 6 month post intervention
general maternal functioning
6 month post intervention
Work and Social Adjustment Scale (WSAS)
Time Frame: 12 month post intervention
general maternal functioning
12 month post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2017

Primary Completion (Anticipated)

June 30, 2022

Study Completion (Anticipated)

December 28, 2022

Study Registration Dates

First Submitted

January 4, 2017

First Submitted That Met QC Criteria

January 4, 2017

First Posted (Estimate)

January 5, 2017

Study Record Updates

Last Update Posted (Actual)

February 15, 2021

Last Update Submitted That Met QC Criteria

February 10, 2021

Last Verified

October 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • MH109662

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

NIMH Data Archive

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Interpersonal Therapy

3
Subscribe